Abbott Laboratories’ (NYSE:ABT) ID NOW test May Be Giving Inaccurate Test Results Due To “User Error”

The US FDA has warned that Abbott Laboratories’ (NYSE:ABT) rapid COVID-19 test might be having accuracy issues that might be due to user error. The FDA cited various studies that have raised concerns about the test’s accuracy when employed in making a quick diagnosis. Abbott’s rapid test could be giving inaccurate results Alex Azar, the […]

Abbott Laboratories (NYSE:ABT) Sponsors The Boston Marathon

Abbott Laboratories (NYSE:ABT) has partnered with Boston Athletic Association (B.A.A.) to become an official sponsor of the Boston Marathon. The sponsorship by Abbott is a way to celebrate the healthy lifestyle of people. According to B.A.A. Executive Director, Tom Grilk, the move by Abbott has underscored Abbott’s mission to increase the wellness and fitness of […]

Abbott Laboratories (NYSE:ABT): Goldman Sachs Group Inc (NYSE:GS) Sees Nutritional Business As Key Driver Of Growth

Boston, MA 10/13/2014 (wallstreetpr) – Goldman Sachs Group Inc (NYSE:GS) expects nutritional business as a key driver for growth opportunities for Abbott Laboratories (NYSE:ABT). The brokerage believes that the company could use the untapped business opportunities in the sector for its future uptick. China Untapped Analyst David Roman said that there were untapped geographies for […]

AbbVie Inc (NYSE:ABBV) and Abbott Laboratories (NYSE:ABT) Win Claims Over Dismissal of AndroGel and Humira

Boston, MA 09/26/2014 (wallstreetpr) – After a long fight AbbVie Inc (NYSE:ABBV) and Abbott Laboratories (NYSE:ABT) have finally won their claims against the dismissal of AndroGel testosterone drug and Humira arthritis drug. There was a lawsuit filed against both of these companies that accused that the above mentioned two drugs caused health plans to pay […]

Goldman Sachs Group Inc (NYSE:GS) Key Takeaways from Transcatheter Cardiovascular Therapeutics Conference

Boston, MA 09/16/2014 (wallstreetpr) – Investment advisor, Goldman Sachs Group Inc (NYSE:GS) analysts have provided key takeaways from the 2014 Transcatheter Cardiovascular Therapeutics or TPT conference. Accordingly, they have retained their Buy rating on the shares of Abbott Pharmaceuticals (NYSE:ABT) and Edwards Lifesciences Corp (NYSE:EW) while they remained Neutral on St. Jude Medical, Inc. (NYSE:STJ) […]

Goldman Sachs Group Inc (NYSE:GS) Lifts Price Target on Abbott Laboratories (NYSE:ABT) Shares

Boston, MA 08/05/2014 (wallstreetpr) – Investment advisor Goldman Sachs Group Inc (NYSE:GS) has boosted its price objective on the shares of healthcare products maker Abbott Laboratories (NYSE:ABT) based on normalized earnings per share and discounted cash flow estimation. However, it had not changed its rating on the stock. It also expects the company to benefit from […]

Shire PLC (ADR) (NASDAQ:SHPG) Rejects $47 Billion Takeover Offer, But More To Come

Boston, MA 06/23/2014 (wallstreetpr) – Shire PLC (ADR) (NASDAQ:SHPG), a $44 billion specialty biopharmaceutical company based in Ireland, rejected at least three takeover offers from AbbVie Inc (NYSE:ABBV). The company declined $46.5 billion purchase offer as its board of directors said the proposal undervalues the company’s prospects. Furthermore, the board said the proposal was “highly conditional.” […]

BIOLASE Inc (NASDAQ:BIOL) Management Changes Announcement Boosts Stock Price

Boston, MA 06/18/2014 (wallstreetpr) – Leading manufacturer and distributor of dental lasers, BIOLASE Inc (NASDAQ:BIOL) announced significant changes in the management with the objective of strengthening its leadership, global competitiveness, and its focus towards professional customers, as well as, their patients. The changes were made following the Delaware Supreme Court order on June 12 on […]

Abbott Laboratories (NYSE:ABT) And Abbvie Inc. Testosterone Lawsuits Consolidated In Chicago Court

Boston, MA 06/13/2014 (wallstreetpr) – Abbott Laboratories (NYSE:ABT) as well as AbbVie Inc. are likely to face consolidated lawsuits in one Chicago court. The lawsuits pertain to the allegations that the two companies had concealed the information about risks of using AndroGel, the testosterone-replacement drug. The case is pending in the U.S. District Court, Northern District […]

AbbVie Inc (NYSE:ABBV) And Abbott Laboratories (NYSE:ABT) To Face Consolidated Lawsuits In Chicago

Boston, MA 06/09/2014 (wallstreetpr) – AbbVie Inc (NYSE:ABBV) and Abbott Laboratories (NYSE:ABT) are alleged to hide risks associated with the testosterone substitute AndroGel. Both the Chicago based drug makers are to face lawsuits in a court in Chicago now while several cases over the same issue are already pending in the U.S. District Court. Judge […]

Abbott Laboratories (NYSE:ABT) Acquires CFR Pharma for $2.9 Billion

Boston, MA 06/06/2014 (wallstreetpr) – There has been an upsurge in Mergers and Acquisitions in the Pharmaceutical and Healthcare Industry in recent times. The latest in the list the takeover of CFR Pharma by Abbott Laboratories (NYSE:ABT). The transaction amounts to $2.9 billion and it will help Abbott in expanding its business in growing markets of Latin […]

Abbott Laboratories (NYSE:ABT) Boasts The Power To Acquire

Boston, MA 05/29/2014 (wallstreetpr) – Abbott Laboratories (NYSE:ABT) announced that it expects its acquisition of Chile’s biggest drugmaker, CFR Pharmaceuticals SA, to close in 3Q 2014. Abbott, earlier this month, offered to acquire CFR for $2.9 billion. The acquisition move adds the string of deals that the company intends to enter as it seeks growth […]

Abbott Laboratories (NYSE:ABT) Acquisition in Latin America

Boston, MA 05/21/2014 (wallstreetpr) – Abbott Laboratories (NYSE:ABT) recently announced that they will be acquiring CFR Pharmaceuticals at an estimated price of $2.9 billion. This would enable the company to make its presence felt in the South American region. ABT will acquire the holding company that collectively holds a 73% share in CFR. Abbott will, […]

Goldman Sachs Group Inc (NYSE:GS) Reiterates Buy On Abbott Laboratories (NYSE:ABT)

Boston, MA 05/20/2014 (wallstreetpr) – Brokerage firm, Goldman Sachs Group Inc (NYSE:GS) has reiterated its rating on the shares of the pharmaceutical company, Abbott Laboratories (NYSE:ABT). The brokerage sees the company at vital cross-roads even as the second half of the current year is expected to witness accelerated sales and earnings per share upside. Implications Post […]

Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley’s Doors For The Sell of Established Drugs

Boston, MA 05/15/2014 (wallstreetpr) – Abbott Laboratories (NYSE:ABT) is a leading name in the field of women’s health, neurology, gastroenterology, thyroid, vitamins, diabetes & urology pain management, anti-infective &  several other therapies. Recently the news came out that the company is seeking the help of Morgan Stanley for the selling of established drugs.   Matter in […]